Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design, synthesis, and evaluation of antitumor activity of 2-arylmethoxy-4-(2-fluoromethyl-biphenyl-3-ylmethoxy) benzylamine derivatives as PD-1/PD-l1 inhibitors.
Zhang F, Zhang H, Zhou S, Plewka J, Wang M, Sun S, Wu C, Yu Q, Zhu M, Awadasseid A, Wu Y, Magiera-Mularz K, Zhang W. Zhang F, et al. Among authors: magiera mularz k. Eur J Med Chem. 2024 Oct 5;276:116683. doi: 10.1016/j.ejmech.2024.116683. Epub 2024 Jul 15. Eur J Med Chem. 2024. PMID: 39032403
An updated patent review on PD-1/PD-L1 antagonists (2022-present).
Uzar W, Kaminska B, Rybka H, Skalniak L, Magiera-Mularz K, Kitel R. Uzar W, et al. Among authors: magiera mularz k. Expert Opin Ther Pat. 2024 Aug;34(8):627-650. doi: 10.1080/13543776.2024.2368237. Epub 2024 Jun 25. Expert Opin Ther Pat. 2024. PMID: 38903044 Review.
1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists.
van der Straat R, Draijer R, Surmiak E, Butera R, Land L, Magiera-Mularz K, Musielak B, Plewka J, Holak TA, Dömling A. van der Straat R, et al. Among authors: magiera mularz k. RSC Med Chem. 2024 Feb 21;15(4):1210-1215. doi: 10.1039/d3md00746d. eCollection 2024 Apr 24. RSC Med Chem. 2024. PMID: 38665826 Free PMC article.
Discovery of bioactive natural products of microbial origin as inhibitors of the PD-1/PD-L1 protein-protein interaction.
Domingo-Contreras E, Tormo JR, Gonzalez-Menendez V, Mackenzie TA, Martín-Serrano J, Magiera-Mularz K, Kitel R, Reyes F, Genilloud O, Fernández-Godino R, Ramos MC, Castillo F. Domingo-Contreras E, et al. Among authors: magiera mularz k. Int J Biol Macromol. 2024 Apr;264(Pt 1):130458. doi: 10.1016/j.ijbiomac.2024.130458. Epub 2024 Feb 28. Int J Biol Macromol. 2024. PMID: 38423421
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m-Terphenyl Derivatives.
Surmiak E, Ząber J, Plewka J, Wojtanowicz G, Kocik-Krol J, Kruc O, Muszak D, Rodríguez I, Musielak B, Viviano M, Castellano S, Skalniak L, Magiera-Mularz K, Holak TA, Kalinowska-Tłuścik J. Surmiak E, et al. Among authors: magiera mularz k. ACS Med Chem Lett. 2023 Dec 14;15(1):36-44. doi: 10.1021/acsmedchemlett.3c00306. eCollection 2024 Jan 11. ACS Med Chem Lett. 2023. PMID: 38229762 Free PMC article.
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors.
Donati G, Viviano M, D'Amore VM, Cipriano A, Diakogiannaki I, Amato J, Tomassi S, Brancaccio D, Russomanno P, Di Leva FS, Arosio D, Seneci P, Taliani S, Magiera-Mularz K, Musielak B, Skalniak L, Holak TA, Castellano S, La Pietra V, Marinelli L. Donati G, et al. Among authors: magiera mularz k. Arch Pharm (Weinheim). 2024 Mar;357(3):e2300583. doi: 10.1002/ardp.202300583. Epub 2023 Dec 18. Arch Pharm (Weinheim). 2024. PMID: 38110703 Free article.
Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies.
Rodriguez I, Kocik-Krol J, Skalniak L, Musielak B, Wisniewska A, Ciesiołkiewicz A, Berlicki Ł, Plewka J, Grudnik P, Stec M, Siedlar M, Holak TA, Magiera-Mularz K. Rodriguez I, et al. Among authors: magiera mularz k. Mol Cancer. 2023 Sep 7;22(1):150. doi: 10.1186/s12943-023-01853-4. Mol Cancer. 2023. PMID: 37679783 Free PMC article.
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2'-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors.
Zhang H, Zhou S, Plewka J, Wu C, Zhu M, Yu Q, Musielak B, Wang X, Awadasseid A, Magiera-Mularz K, Wu Y, Zhang W. Zhang H, et al. Among authors: magiera mularz k. J Med Chem. 2023 Aug 10;66(15):10579-10603. doi: 10.1021/acs.jmedchem.3c00731. Epub 2023 Jul 26. J Med Chem. 2023. PMID: 37496104
29 results